Contraception News and Research RSS Feed - Contraception News and Research

Researchers aim to design a better male contraceptive pill

Researchers aim to design a better male contraceptive pill

Women can choose from a wide selection of birth control methods, including numerous oral contraceptives, but there's never been an analogous pill for men. That's not for lack of trying: For many years, scientists have attempted to formulate a male pill. Finally, a group of researchers has taken a step toward that goal by tweaking some experimental compounds that show promise. [More]
New research reveals European women's attitudes towards sexual behaviours, emergency contraceptive pill

New research reveals European women's attitudes towards sexual behaviours, emergency contraceptive pill

New research released on International Women’s Day, reveals more than three in four European women (77%) are aware of the morning after pill as an option for managing the risk of an unplanned pregnancy after unprotected sex or contraceptive failure. [More]
New study assesses link between depression, anxiety and antidepressants and outcome of IVF

New study assesses link between depression, anxiety and antidepressants and outcome of IVF

Depression and anxiety, and not necessarily the use of antidepressant medication, are associated with lower pregnancy and live birth rates following in vitro fertilisation, according to a large register study from Karolinska Institutet in Sweden. The findings are published in the journal Fertility & Sterility and can be of interest to clinicians treating infertility and for women with depression or anxiety planning to undergo fertility treatment. [More]
Woman's Condom prequalified by WHO/UNFPA

Woman's Condom prequalified by WHO/UNFPA

The Woman's Condom, a new female condom designed to be easy to use and more acceptable to women and their partners, has been prequalified by the World Health Organization/United Nations Population Fund. The approval marks a critical step forward in expanding options for female-initiated dual protection from pregnancy and sexually transmitted infections (STIs), including HIV. [More]
Preventing the spread of Zika: an interview with Professor John Oxford

Preventing the spread of Zika: an interview with Professor John Oxford

The link between the Zika virus and Guillain-Barré on the one hand, and pregnancy and the virus affecting the fetus in terms of microcephaly on the other, is still not confirmed conclusively. [More]
NOF provides evidence-based guidance to help children and adolescents attain optimal bone health

NOF provides evidence-based guidance to help children and adolescents attain optimal bone health

The National Osteoporosis Foundation today released a position statement providing evidence-based guidance and a national implementation strategy to help children and adolescents achieve optimal bone health, or what is known as "peak bone mass," early in life. [More]
Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Eisai Inc. announced today that the U.S. Food and Drug Administration approved Halaven (eribulin mesylate) Injection (0.5 mg per mL) for the treatment of patients with unresectable or metastatic liposarcoma who have received a prior anthracycline-containing regimen. [More]
Smartphone app helps increase contraceptive use among married rural women in India

Smartphone app helps increase contraceptive use among married rural women in India

A smartphone app containing motivational videos developed to help married rural women in India better understand contraceptive choices led to a dramatic increase in the number of women using modern family planning methods in just a few months, new Johns Hopkins Center for Communication Programs (CCP) research suggests. [More]
Estrogen helps women fight flu virus better than men

Estrogen helps women fight flu virus better than men

Estrogen dramatically reduced the amount of flu virus that replicated in infected cells from women but not from men, a new study by researchers at the Johns Hopkins Bloomberg School of Public Health shows. [More]
Women suffering from blood clots can safely take hormone replacement therapy with anticoagulants

Women suffering from blood clots can safely take hormone replacement therapy with anticoagulants

New research published online today in Blood, the Journal of the American Society of Hematology (ASH), is the first to demonstrate that women on blood thinners can take estrogen-containing contraception or hormone replacement therapy without an increased risk of blood clots or uterine bleeding. [More]
Incorporating postpartum contraceptive services across the continuum of reproductive healthcare

Incorporating postpartum contraceptive services across the continuum of reproductive healthcare

Approximately one-quarter of inter-birth intervals in low- and middle-income countries are less than 24 months in length, exposing infants to risks of prematurity, low birthweight, and death. Increased evidence of these health risks has emerged in the past few decades and, after a period of neglect, interest in postpartum family planning has followed, supported by organizations like WHO and USAID. [More]
Lilly, Merck announce another immuno-oncology collaboration

Lilly, Merck announce another immuno-oncology collaboration

Eli Lilly and Company and Merck, known as MSD outside the United States and Canada, today announced another immuno-oncology collaboration that will evaluate abemaciclib (LY2835219), Lilly's cyclin-dependent kinase (CDK) 4 and 6 inhibitor, and Merck's KEYTRUDA (pembrolizumab) in a Phase I study across multiple tumor types. [More]
Lilly, Merck expand oncology clinical trial collaboration

Lilly, Merck expand oncology clinical trial collaboration

Eli Lilly and Company and Merck, known as MSD outside the United States and Canada, today announced the extension of an existing collaboration to evaluate the safety and efficacy of the combination of Lilly's ALIMTA (pemetrexed for injection) and Merck's KEYTRUDA (pembrolizumab) in a pivotal Phase III study in first-line nonsquamous non-small cell lung cancer (NSCLC). [More]
Cotellic (cobimetinib) approved to be used in combination with vemurafenib for melanoma treatment

Cotellic (cobimetinib) approved to be used in combination with vemurafenib for melanoma treatment

The U.S. Food and Drug Administration today approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to other parts of the body or can't be removed by surgery, and that has a certain type of abnormal gene (BRAF V600E or V600K mutation). [More]
Researchers examine risk of four common types of ovarian cancer in women with different childbearing patterns

Researchers examine risk of four common types of ovarian cancer in women with different childbearing patterns

The more children a woman has or whether a woman has had her fallopian tubes cut lowers the risk of different types of ovarian cancer to different levels, according to new research presented at the 2015 National Cancer Research Institute Cancer Conference today (Tuesday). [More]
Impact of physicians' unconscious attitudes toward disabled and LGBT patients

Impact of physicians' unconscious attitudes toward disabled and LGBT patients

Physicians' unconscious attitudes toward special patient populations like disabled and LGBT patients may be partially responsible for poorer overall health observed in these communities, according to a Rowan University professor of family medicine. [More]
Osteopathic physicians, researchers to present clinical and research updates at OMED 15

Osteopathic physicians, researchers to present clinical and research updates at OMED 15

Osteopathic physicians, researchers and aligned medical professionals will present clinical and research updates in 15 specialties at OMED 15 in Orlando October 17-21. [More]
Research shows more than 30,000 women die from cardiovascular disease in UK

Research shows more than 30,000 women die from cardiovascular disease in UK

More than 30,000 women die from coronary heart disease in the UK every year with over 700,000 women living with the consequences of heart disease and stroke, according to research published by The British Heart Foundation ahead of World Heart Day on 29th September. [More]
Johns Hopkins study highlights need for effective postpartum interventions for women with pregnancy complications

Johns Hopkins study highlights need for effective postpartum interventions for women with pregnancy complications

Citing an analysis of more than 26,000 Maryland Medicaid claims, Johns Hopkins researchers report evidence that poor women with recent complications during their pregnancies are using the emergency room at higher rates after delivery and may not be getting the postpartum care and follow-up they need to prevent further health problems. [More]
FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced that the U.S. Food and Drug Administration approved LONSURF (trifluridine and tipiracil), formerly known as TAS-102, for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy. [More]
Advertisement
Advertisement